Centro de ingeniería genética y biotecnologíA "Efecto regenerador del Factor de Crecimiento Epidérmico en la neuropatía periférica" Trabajo presentado como propuesta a



Descargar 122.79 Kb.
Página3/3
Fecha de conversión28.11.2018
Tamaño122.79 Kb.
1   2   3

Acevedo ME, Leon N, Pérez-Saad H, and Garcia JD (2000). Protective effect of a mixture of gangliosides in acrylamide neuropathy in mice. Rev Neurol 30:1097-1098.

Acosta JB, Savigne W, Valdez C, Franco N, Alba JS, Del Río A, López-Saura P, Guillén G, López E, Herrera L, Fernández-Montequín J (2006). Epidermal growth factor intralesional infiltrations can prevent amputation in patients with advanced diabetic fèoot wounds. Int Wound J 3: 232-239.

Arezzo JC, Litwak MS, Zotova EG (2011). Correlation and dissociation of electrophysiology and histopathology in the assessment of toxic neuropathy. Toxicol Pathol. 39:46-51.

Andersson KE (2011). Mechanisms of penile erection and basis for pharmacological treatment of erectile dysfunction. Pharmacol Rev 63:811-859.

Andersen H, Stålberg E, Falck B (1997). F-wave latency, the most sensitive nerve conduction parameter in patients with diabetes mellitus. Muscle Nerve. 20:1296-302.

Barrette B, Hébert M-A, Filali M, Lafortune K, Vallières N, Gowing G, Julien J-P, and Lacroix S (2008). Requirement of Myeloid Cells for Axon Regeneration. J Neurosci 28:9363–9376.

Brites P, Mooyer PA, El Mrabet L, Waterham HL, Wanders JA (2009). Plasmalogens participate in very-long fatty acido-induced pathology. Brain 132: 482-92.

Carpenter G (2000). The EGF receptor: a nexus for trafficking and signaling. Bioessays 22: 697-707

Colquhoun D (2006). The quantitative analysis of drug-receptor interactions: a short history. Trends Pharmacol. Sci. 27:149-157.

Crobbe JC, Cotman CJ, Cameron AJ, Schlumbohm JP, Rhodes JS, Metten P, Wahlsten D (2003). Strain differences in three measures of ethanol intoxication in mice : The screen, dowel and grip strength tests. Genes Brain Behav 2 : 201-213.

Del Cerro M, Cogen J, del Cerro C (1980). Stevenel's Blue, an excellent stain for optical microscopical study of plastic embedded tissues. Microscopica Acta 8:117-21.

Dyck PJ, Herrmann DN, Staff NP, Dyck PJD (2013). Assessing Decreased Sensation and Increased Sensory Phenomena in Diabetic Polyneuropathies. Diabetes 62: 3677-3686.

Doetsch F, Petreanu L, Caille I, Garcia-Verdugo JM, Alvarez-Buylla A (2002). EGF converts transit-amplifying neurogenic precursors in the adult brain into multipotent stem cells. Neuron 36:1021-1034.

Du T, Li B, Liu S, Zang P, Prevot V, Hertz L, Peng L (2009). ERK phosphorylation in intact, adult brain by alpha(2)-adrenergic transactivation of EGF receptors. Neurochem Int 55: 593-600.

Edwards PM (1975). Neurotoxicity of acrylamide and its analogues and effects of these analogues and other agents on acrylamide neuropathy. Br J Ind Med 32: 31-38.

Fennell TR, Snyder R, Hansen B, Friedman M (2015). Dosimetry of Acrylamide and Glycidamide Over the Lifespan in a 2-Year Bioassay of Acrylamide in Wistar Han Rats. Toxicol Sci 146: 386-394.

Fernández-Montequin JI, Infante E, Valenzuela C, Franco N, Savigne W, Artaza H, González C, Eliseo O, García E, Berlanga J, Silva R, Betancourt BY, López PA (2007). Intralesional injections of Citoprot-P (recombinant human epidermal growth factor) in advanced diabetic foot ulcers with risk of amputation. Int. Wound J. 4:333-343.

Fernández-Montequin JI, Betancourt BY, Leyva G, Mola EL, Galán K, Ramírez-Nava M, Bermúdez S, García E, Berlanga J, Silva R, García-Silveiro M, Martínez LH (2009). Intralesional administration of epidermal growth factor-based formulation (Heberprot-P) in chronic diabetic foot ulcer: treatment up to complete wound closure. Int. Wound J. 6:67-72.

Fisher MA (2007). F-waves -physiology and clinical uses. The ScientificWorld J 7: 144-160.

Fisher MA (2014). F-waves in diabetes mellitus: Answers and questions. Muscle Nerve 49:783-785.

Forbes JM and Cooper ME (2013). Mechanisms of diabetic complications. Physiol. Rev. 93:137-188.

García del Barco D, Pérez-Saad H, Rodríguez V, Marín J, Falcón V, Matín J, Cibrian D, Berlanga J (2011). Therapeutic effect of the combined use of growth hormone releasing peptide-6 and epidermal growth factor in an axonopathy model. Neurotox Res 19:195-209.

Guilloux JP, Seney M, Edgar N, and Sibille E (2011). Integrated behavioral z-scoring increases the sensitivity and reliability of behavioral phenotyping in mice: relevance to emotionality and sex. J. Neurosci Methods 197:21-31.

Hwang DH, Lee HJ, Park IH, Seok JI, Kim BG, Joo IS, Kim SU (2009). Intrathecal transplantation of human neural stem cells overexpressing VEGF provides behavioral improvement, disease onset delay and survival extension in transgenic ALS mice. Gene Ther 16: 1234–1244.

Higashiyama S, Iwabuki H, Morimoto C, Hieda M, Inoue H, Matsushita N (2008). Membrane-anchored growth factors, the epidermal growth factor family: beyond receptor ligands. Cancer Sci. 99:214-220.

Horn M, Baumann R, Pereira JA, Sidiropoulos PNM, Somandin C, Welzl H, Stendel C, Lühmann T, Wessig C, Toyka KV, Relvas JB, Senderek J, Suter U (2012). Myelin is dependent on the Charcot-Marie-Tooth Type 4H disease culprit protein FRABIN/FGD4 in Schwann cells. Brain 135: 3567-83.

Hough LB, Nalwalk JW, Cleary RA, Phillips JG, Fang C, Weizhu Y, Ding X (2014). Deficit in neuronal cytochrome P450 activity attenuate opioid analgesia but not opioid side effects. Eur. J. Pharmacol. 740 : 256-262.

Karimi-Abdolrezaee S, Schut D, Wang J, and Fehlings MG (2012). Chondroitinase and growth factors enhance activation and oligodendrocyte differentiation of endogenous neural precursor cells after spinal cord injury. PLoS One 7: e37589.

Kinoshita A, Yamada K, Hayakawa T, Kataoka K, Mushiroi T, Cohmura E, Mugamy H (1990). Modification of anoxic neuronal injury by human recombinant epidermal growth factor and its possible mechanism. J. Neurosci. Res. 25:324-330.

Knapp PE and Adams MH (2004). Epidermal growth factor promotes oligodendrocyte process formation and regrowth after injury. Exp Cell Res 296:135-144.

LoPachin RM, Balaban CD, Ross JF (2003). Acrylamide axonopathy revisited. Toxicol Appl Pharmacol 188: 135–153.

LoPachin RM, Lehning EJ, Opanashuk LA, and Jortner BS (2000). Rate of neurotoxicant exposure determines morphologic manifestations of distal axonopathy. Toxicol Appl Pharmacol 167:75-86.

LoPachin RM, Ross JF, and Lehning EJ (2002a). Nerve terminals as the primary site of acrylamide action: a hypothesis. Neurotoxicology 23:43-59.

LoPachin RM, Ross JF, Reid ML, Das S, Manssukhani S, Lahning EJ (2002b) Neurological evaluation of toxic axonopathies in rats: acrylamide and 2,5-hexanedione. Neurotoxicology 23:95-110.

Pan H, Jian F, Lin L, Chen N, Zhang C, Zhang Z, Ding Z, Wang Y, Cui L, Kimura J (2014). F-wave latencies in patients with diabetes mellitus. Muscle Nerve 49:804-808.

Planas AM Justicia C, Soriano MA, Ferrer I (1998). Epidermal growth factor receptor in proliferating reactive glia following transient focal ischemia in the rat brain. Glia 23:120-129.

Sachs BD, Akasofu K, McEldowney SS (1994). Effects of copulation on apomorphine-induced erection in rats. Pharmacol. Biochem. Behav. 48:423-428.

Sickles DW, Sperry AO, Testino A, Friedman (2007). Acrylamide effects on kinesin-related proteins of the mitotic/meiotic spindle. Toxicol Appl Pharmacol 222:111-121.

Simpson DL, Morrison R, de Vellis J, Herschman HR (1982). Epidermal growth factor binding and mitogenic activity on purified populations of cells from the central nervous system. J Neurosci Res 8:453-462.

SunY, Goderie SK, and Temple S (2005). Asymmetric distribution of EGFR receptor during mitosis generates diverse CNS progenitor cells. Neuron 45:873-886.

Tareke E, Rydberg P, Karlsson P, Eriksson S, Törnqvist M (2002). Analysis of acrylamide, a carcinogen formed in heated foodstuffs. J Agric Food Chem 50: 4998-5006.

Toma JG, Pareek S, Barker P, Mathew TC, Murphy Ra, Acheson A, Miller FD (1992). Spatiotemporal increases in epidermal growth factor receptors following peripheral nerve injury. J Neurosci 12:2504-2515.

Ulkay MB, Aktaş A, Aksoy O, Haktanir D, Bozkurt HH (2013). Comparison of fixation methods for peripheral nerve fiber. Kafkas Univ Vet Fak Derg 19: 51-56

Watanabe T, Kaji R, Oka N, Bara W, Kimura J (1994). Ultra-high dose methylcobalamin promotes nerve regeneration in experimental acrylamide neuropathy. J Neurol Sci 122:140-143.

Xian CJ, Zhou X-F (1999). Roles of transforming growth factor-α and related molecules in the nervous system. Molecular Neurobiol. 20:157-183.

Xian CJ, Zhou X-F (2004). EGF family of growth factors: Essential roles and functional redundancy in the nerve system. Frontiers in Bioscience 9: 85-92.



Yamada M, Ikeuchi T, and Hatanaka H (1997). The neurotrophic action and signaling of epidermal growth factor. Progress in neurobiol 51: 19-37.

Yanagihashi R, Yamanouchi K, Ishikawa T (1991). The effect of apomorphine on the hippocampal field potential in freely moving rats: pharmacological evidence of the involvement of D2 receptors. Neuropharmacology 30: 177-182.

Compartir con tus amigos:
1   2   3


La base de datos está protegida por derechos de autor ©odont.info 2017
enviar mensaje

    Página principal